Biology Reference
In-Depth Information
479.
Innominato PF, Levi FA, Bjarnason GA. Chronotherapy and the molecular clock: clin-
ical implications in oncology.
Adv Drug Deliv Rev
. 2010;62(9-10):979-1001.
480.
Giacchetti S, Dugue PA, Innominato PF, et al. Sex moderates circadian chemotherapy
effects on survival of patients with metastatic colorectal cancer: a meta-analysis.
Ann
Oncol
. Dec 2012;23(12):3110-3116.
481.
Rivard GE, Infante-Rivard C, Dresse MF, Leclerc JM, Champagne J. Circadian time-
dependent response of childhood lymphoblastic leukemia to chemotherapy: a long-
term follow-up study of survival.
Chronobiol Int
. Jun 1993;10(3):201-204.
482.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics.
CA
Cancer J Clin
. 2011;61(2):69-90.
483.
Saunders NA, Simpson F, Thompson EW, et al. Role of intratumoural heterogeneity
in cancer drug resistance: molecular and clinical perspectives.
EMBO Mol Med
. 2012;4
(8):675-684.
484.
Stein CJ, Colditz GA. Modifiable risk factors for cancer.
Br J Cancer
. 2004;90
(2):299-303.
485.
McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breast cancer-
epidemiology, risk factors, and genetics.
BMJ
. 2000;321(7261):624-628.
Previous Page
Next Page
Progress in Molecular Biology and Translational Science
Search WWH ::
Custom Search
Home